We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Very-low-density-lipoprotein Triglyceride (VLDL-TG) Uptake in Visceral Fat

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00893893
First Posted: May 6, 2009
Last Update Posted: August 25, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Esben Søndergaard, University of Aarhus
  Purpose

Purpose:

To investigate the uptake of VLDL-TG in visceral fat in lean and overweight individuals


Condition
Healthy Obesity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Very-low-density-lipoprotein Triglyceride(VLDL-TG) Uptake in Visceral Fat

Further study details as provided by Esben Søndergaard, University of Aarhus:

Biospecimen Retention:   Samples With DNA
Blood samples Adipose tissue samples

Estimated Enrollment: 16
Study Start Date: May 2009
Study Completion Date: January 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Lean premenopausal women
2
Visceral obese premenopausal women

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy volunteers
Criteria

Inclusion Criteria:

  • Healthy
  • Age: 20-50 years
  • Premenopausal

Exclusion Criteria:

  • Smoking
  • Alcohol abuse
  • Use of medications
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00893893


Locations
Denmark
Department of Endocrinology M, Aarhus Hospital
Aarhus C, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Esben Søndergaard, MD, ph.d., University of Aarhus
ClinicalTrials.gov Identifier: NCT00893893     History of Changes
Other Study ID Numbers: ES-0003
First Submitted: May 5, 2009
First Posted: May 6, 2009
Last Update Posted: August 25, 2011
Last Verified: August 2011

Keywords provided by Esben Søndergaard, University of Aarhus:
Obesity
Lipid metabolism
VLDL